99 related articles for article (PubMed ID: 1480851)
1. The distinction of Hodgkin's disease from anaplastic large cell lymphoma.
Frizzera G
Semin Diagn Pathol; 1992 Nov; 9(4):291-6. PubMed ID: 1480851
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
3. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma.
Harris NL
Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853
[TBL] [Abstract][Full Text] [Related]
4. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
5. CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall.
Perkins PL; Ross CW; Schnitzer B
Arch Pathol Lab Med; 1992 Nov; 116(11):1192-6. PubMed ID: 1359849
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
7. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
8. [Argyrophilic proteins of nucleolar organizers regions as markers of malignancy grade of anaplastic large-cell lymphoma and Hodgkin's lymphoma].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsin NN; Sholokhova EN; Osmanov ShSh
Arkh Patol; 2004; 66(5):30-4. PubMed ID: 15575384
[TBL] [Abstract][Full Text] [Related]
9. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
10. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
13. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
[TBL] [Abstract][Full Text] [Related]
15. The interface of Hodgkin's disease and anaplastic large cell lymphoma.
Chittal SM; Delsol G
Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988
[TBL] [Abstract][Full Text] [Related]
16. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
18. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications.
Kinney MC; Greer JP; Glick AD; Salhany KE; Collins RD
Pathol Annu; 1991; 26 Pt 1():1-24. PubMed ID: 1849627
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-morphologic reconsideration of anaplastic lymphoma. Retrospective study of 60 patients with aggressive clinical course and multiple recurrences].
Ageitos AG; Rivas C; Lobo F; Obeso G; Marcos B; Gonzalo I; Echezarreta G; Delgado RG; Oliva H
Rev Clin Esp; 1996 Dec; 196(12):821-7. PubMed ID: 9132858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
